Inventor · disambiguated record
Jürgen Klar
Also filed as: KLAR JUERGEN · KLAR JURGEN · KLAR JÜRGEN
14 granted patents·14 pending applications·50 citations·filing 2011–2021
90Inventor score
Top patents by PatentIndex Score
28 records- 0190US10202369B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Feb 12, 2019·4 cites·26 claims
- 0289US10472354B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2018·Granted Nov 12, 2019·3 cites·13 claims
- 0389US10174016B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2015·Granted Jan 8, 2019·4 cites·34 claims
- 0489US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 0588US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 0687US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 0786US11142523B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2019·Granted Oct 12, 2021·2 cites·16 claims
- 0886US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 0981US10183937B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Jan 22, 2019·4 cites·22 claims
- 1079US9765070B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·4 cites·9 claims
- 1173US2023053411A11,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2021·Application pending·0 cites
- 1271US9040566B2Adenosine A1 agonists for the treatment of glaucoma and ocular hypertensionKLAR JÜRGEN·Filed 2011·Granted May 26, 2015·2 cites·11 claims
- 1361US9040691B2Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitorsKLAR JÜRGEN·Filed 2012·Granted May 26, 2015·1 cites·8 claims
- 1459US2023065629A1Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 1551US11208400B2Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereofBAYER AG·Filed 2017·Granted Dec 28, 2021·0 cites·17 claims
- 1649US2012058983A1Adenosine A1 agonists for the treatment of glaucoma and ocular hypertensionKLAR JUERGEN·Filed 2011·Application pending·0 cites
- 1747US2014179745A1Topical ophthalmological pharmaceutical composition containing regorafenibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 1846US2015328145A1Topical ophthalmological pharmaceutical composition containing regorafenibHEINRICH KELDENICH PETRA·Filed 2013·Application pending·0 cites
- 1946US2016318866A1Substituted bipiperidinyl derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2045US2023027985A1Substituted hydantoinamides as adamts7 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 2145US2015164790A1Topical Ophthalmological Pharmaceutical Composition containing AxitinibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 2243US2014235678A1Topical Ophthalmological Pharmaceutical Composition containing SorafenibBÖTTGER MICHAEL·Filed 2012·Application pending·0 cites
- 2343US2016009776A1Pdgfrbeta-fc fusion proteins and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2439US2015174096A1Topical ophthalmological pharmaceutical composition containing sunitinibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 2537US2015141448A1Topical Ophthalmological Pharmaceutical Composition containing PazopanibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 2637US2015165028A1Topical ophthalmological pharmaceutical composition containing cediranibHEINRICH KELDENICH PETRA·Filed 2013·Application pending·0 cites
- 2735US2014296301A1Topical ophthalmological pharmaceutical composition containing regoragenibBOTTGER MICHAEL·Filed 2012·Application pending·0 cites
- 2831US10047096B2Substituted pyridobenzodiazepinone-derivatives and use thereofBayer Pharma AG·Filed 2015·Granted Aug 14, 2018·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →